| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Jun―06 |
Comparison of requirements for clinical study of SARS-CoV-2 antigen test kits in China, the USA and Europe |
Yunfeng Lyu, Yuting Zhu, Ying Zhang, Yuanyuan Hou, Yining Zhang, Jingyun He, Gang Deng |
| 2 |
[GO] |
2022―Feb―21 |
China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents |
Yunfeng Lv, Yu Gao, Jingyun He, Chao Xu, Rongzhi Liu, Shengwei Zheng, Li Fang, Congyin Han, Ran Li |
| 3 |
[GO] |
2021―Nov―22 |
Special Focus Issue - COVID-19: bioanalytical considerations, contributions and lessons - part 2 |
Chad J Briscoe, Matthew Barfield |
| 4 |
[GO] |
2021―Nov―18 |
Testing in the workplace: finding a path through a pandemic |
Jameson Briscoe |
| 5 |
[GO] |
2021―Nov―15 |
Key points of technical review for the registration of SARS-CoV-2 nucleic acid tests in China |
Hongran Li, Tong Jiao, Peirong Wang, Juanjuan An, Gang Deng, Lei Sun, Jinchun Dong |
| 6 |
[GO] |
2021―Oct―14 |
Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective |
Jeremy Baldwin, Sakshi Piplani, Isaac G Sakala, Yoshikazu Honda-Okubo, Lei Li, Nikolai Petrovsky |
| 7 |
[GO] |
2021―Sep―13 |
Deploying a rapid point of care polymerase chain reaction test for SARS-CoV-2 in a clinical research unit to ensure healthy volunteer safety |
Radboud van Trigt, Jason Neat, Jan Leendert Brouwer, Amanda Hays, Hans Westerhof |
| 8 |
[GO] |
2021―Aug―31 |
Volumetric absorptive microsampling: its use in COVID-19 research and testing |
James Rudge, Stuart Kushon |
| 9 |
[GO] |
2021―Aug―31 |
A minireview on nanoparticle-based sensors for detection of coronaviruses |
Elaheh Rahimpour, Farzaneh Lotfipour, Abolghasem Jouyban |
| 10 |
[GO] |
2021―Aug―18 |
Special Focus Issue - COVID-19: bioanalytical considerations, contributions and lessons - part 1 |
Sankeetha Nadarajah |
| 11 |
[GO] |
2021―Aug―10 |
COVID-19’s impact on bioanalytical labs |
Amy Lavelle, Janine Micheli |
| 12 |
[GO] |
2021―Aug―06 |
Efficiency of pooled surveillance testing in academic labs to detect and inhibit COVID-19 outbreaks |
John C Sitko, James Jordan Steel, Erin A Almand, Christopher A Cullenbine, Joseph W Rohrer, Douglas P Wickert, Steven CM Hasstedt |
| 13 |
[GO] |
2021―Jul―22 |
Detection of SARS-CoV-2 at the point of care |
Michael J Loeffelholz, Yi-Wei Tang |
| 14 |
[GO] |
2021―Jul―21 |
Rapid diagnostics for SARS-CoV-2 virus: point-of-care testing and lessons learned during the pandemic |
Trieu Nguyen, Anders Wolff |
| 15 |
[GO] |
2021―Jul―19 |
How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis |
Melanie Anderson |
| 16 |
[GO] |
2021―Jul―19 |
Lessons learned from the COVID pandemic and its impact on bioanalysis and drug development |
Enaksha R Wickremsinhe, Catherine L Brockus, Anthony T Murphy |
| 17 |
[GO] |
2021―Feb―04 |
Adaptation of Elecsys® anti-severe acute respiratory syndrome coronavirus-2 immunoassay to dried blood spots: proof of concept |
Alexandre Marchand, Ingrid Roulland, Florian Semence, Magnus Ericsson |
| 18 |
[GO] |
2021―Jan―11 |
Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests |
Hongran Li, Jingyun He, Wen Bao, Peirong Wang, Yunfeng Lv, Chao Xu, Peng Hu, Yu Gao, Shengwei Zheng, Juanjuan An, Gang Deng, Jinchun Dong |
| 19 |
[GO] |
2020―Dec―16 |
China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval |
Yunfeng Lv, Jingyun He, Rongzhi Liu, Yu Gao, Chao Xu, Peng Hu, Shengwei Zheng, Li Fang, Ran Li, Congyin Han, Juanjuan An, Jinchun Dong |
| 20 |
[GO] |
2020―Dec―15 |
Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays |
Theodore T Zava, David T Zava |
| 21 |
[GO] |
2020―Sep―11 |
How ADA methodology informs SARS-CoV-2 assay development |
Caroline Becker |
| 22 |
[GO] |
2020―Aug―21 |
Safety considerations in the bioanalytical laboratories handling specimens from coronavirus disease 2019 patients |
Zhuo Chen, Timothy W Sikorski |
| 23 |
[GO] |
2020―Jul―31 |
Could breath analysis by MS could be a solution to rapid, non-invasive testing for COVID-19? |
Heather J Walker, Michael M Burrell |
| 24 |
[GO] |
2020―Jun―26 |
Bioanalytical research and training in academia during the COVID-19 pandemic |
Frank Klont, Gérard Hopfgartner |
| 25 |
[GO] |
2020―Jun―23 |
Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience |
Emirena Garrafa, Duilio Brugnoni, Mosè Barbaro, Laura Andreoli, Emanuele Focà, Massimo Salvetti, Francesco Castelli, Franco Franceschini, Simone Piva, Maria Lorenza Muiesan, Nicola Latronico, Rosella Levaggi |
| 26 |
[GO] |
2020―Jun―12 |
Virtual drug testing: redefining sample collection in a global pandemic |
Matthew N Fedoruk |
| 27 |
[GO] |
2020―May―26 |
Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond |
Sumit Kar, Rafiqul Islam |
| 28 |
[GO] |
2020―Apr―15 |
Exhaled breath condensate as a potential specimen for diagnosing COVID-19 |
Maryam Khoubnasabjafari, Vahid Jouyban-Gharamaleki, Reza Ghanbari, Abolghasem Jouyban |
| 29 |
[GO] |
2020―Apr―14 |
Managing bioanalytical studies during the COVID-19 pandemic: an overview |
Peter Pruim, Naomi Teekamp |
